Table 3.

Subjects with seroprotection, by HAI and MN tests, vaccine and placebo recipients.

	HAI	MN
Vaccine group	No.	% (95% CI)	No.	% (95% CI)
A/H1N1	30	100 (88.43–100)	28	93.33 (77.93–99.18)
A/H3N2	30	100 (88.43–100)	26	86.67 (69.28–96.24)
B	26	86.67 (69.28–96.24)	30	100 (88.43–100)
Placebo group
A/H1N1	10	33.33 (17.29–52.81)	16	53.33 (34.33–71.66)
A/H3N2	19	63.33 (43.86–80.07)	10	33.33 (17.29–52.81)
B	5	16.67 (5.64–34.72)	24	80.00 (61.43–92.29)